Thursday, March 16, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

First Case of Novel Coronavirus in France

by Global Biodefense Staff
May 8, 2013

Novel Coronavirus (Rocky Mountain Labs)French health authorities today announced a 65-year old citizen is hospitalized in intensive care with an acute respiratory infection after having contracted the emerging novel coronavirus (nCoV). 

Where or how the patient contracted nCoV is still being investigated, but the Health Ministry reports the Frenchman fell ill in April after returning from a trip to the United Arab Emirates.

Laboratory analysis by the Pasteur Institute confirmed the virus as nCoV. French government surveillance screening programs have identified 19 suspicious cases thus far, but this is the only case to date that has been positive for the emerging disease.

The nCoV has claimed seven lives since it was first identified in September 2012. Most cases have been in the Middle Eastern countries of Jordan, Qatar, Saudi Arabia and the United Arab Emirates; three cases in the United Kingdom were linked to an infected family member who had recently traveled from Saudi Arabia.

“While the cases are sporadic, we need to understand more about how people are falling ill with this disease…we are concerned about possible human-to-human transmission, even if limited,” said Glenn Thomas, a World Health Organization spokesman (Source: Wall Street Journal).

Tags: CoronavirusEmerging ThreatsMERS-CoV

Related Posts

New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.
Policy + Initiatives

Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.

December 7, 2022
Why Do Some of the Outbreak Genomes Have More Mutations Than Others?
Biosurveillance

Virginia Institutes Partner to Join National Pathogen Genomics Centers of Excellence Network

October 25, 2022
Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations
Medical Countermeasures

Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations

October 25, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC